Cytoprotective role of DL-α-Lipoic acid in cyclophosphamide induced myocardial toxicity

Molecular and Cellular Biochemistry

Volumn 276, Issue 1-2, 2005, Pages 39-44

  Mythili, Y ^a   Sudharsan, P T ^a   Varalakshmi, P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

ATPases; Cyclophosphamide; Heart; Lipoic acid; Marker enzymes

Indexed keywords

ADENOSINE TRIPHOSPHATE DERIVATIVE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CREATINE KINASE; CYCLOPHOSPHAMIDE; LACTATE DEHYDROGENASE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARDIOTONIC AGENTS; CYCLOPHOSPHAMIDE; CYTOPROTECTION; HEART; MALE; MYOCARDIUM; RATS; RATS, WISTAR; THIOCTIC ACID;

EID: 24144493755     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-2735-7     Document Type: Article

References (45)

1. C Dollery 1999 Cyclophosphamide. In: C. Dollery (ed)., Therapeutic Drugs Churchill Livingstone Edinburg pp. 349-353
2. Fraiser LH, Kanekal S, Kehrer JP: Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42: 781-795, 1991 1723374
3. Struck RF, Kari P, Kalin J, Montgomery JA, Marinello AJ, Love J, Bansal SK, Gurtoo HL: Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated rats. Biochem Biophys Res Commun 120: 390-396, 1984 10.1016/0006-291X(84)91266-X
4. Frishman WH, Sung HM, Yee HC, Liu LL, Keefe D, Einzig AI, Dutcher J: Cardiovascular toxicity with cancer chemotherapy. Curr Probl Cancer 21: 301-360, 1997 9442980
5. Dorr RT, Lagel K: Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro. Chem Biol Interact 93: 117-128, 1994 10.1016/0009-2797(94)90091-4
6. Lee CK, Harman GS, Hohl RJ, Gingrich RD: Fatal cyclophosphamide cardiomyopathy: Its clinical course and treatment. Bone Marrow Transplant 18: 573-577, 1996 8879620
7. Sulkowska M, Sulkowski S: The effect of pentoxifylline on ultrastructural picture of type II alveolar epithelial cells and generation of reactive oxygen species during cyclophosphamide-induced lung injury. J Submicrosc Cytol Pathol 29: 487-496, 1997 9397585
8. Machlin LJ, Bendich A: Free radical tissue damage: Protective role of antioxidant nutrients. FASEB J 1: 441-445, 1987 3315807
9. Patel MS, Roche TE: Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 4: 3224-3233, 1990 2227213
10. Packer L, Witt EH, Tritschler HJ: Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995 7649494
11. Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, Packer L: Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 44: 1637-1649, 1992 10.1016/ 0006-2952(92)90482-X
12. Sumathi R, Jayanthi S, Kalpanadevi V, Varalakshmi P: Effect of DL alpha-lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharmacol Res 27: 309-318, 1993 10.1006/phrs.1993.1031
13. Sumathi R, Baskaran G, Varalakshmi P: Relationship between glutathione and DL alpha-lipoic acid against cadmium-induced hepatotoxicity. Jpn J Med Sci Biol 49: 39-48, 1996 8806036
14. Balachandar AV, Malarkodi KP, Varalakshmi P: Protective role of DLalpha-lipoic acid against adriamycin-induced cardiac lipid peroxidation. Hum Exp Toxicol 22: 249-254, 2003 10.1191/0960327103ht358oa
15. Okinaka S, Sugita H, Momoi H, Toyokura Y, Watanabe T, Ebashi F, Ebashi S: Cysteine-stimulated serum creatine kinase in health and disease. J Lab Clin Med 64: 299-305, 1964 14202791
16. J King 1965 The dehydrogenases or oxidoreductases- lactacte dehydrogenase. In: D. Van (ed.), Practical Clinical Enzymology Nostrand Company Limited London pp. 83-93
17. J King 1965 The transferases-alanine and aspartate transaminases. In: D. Van (ed.), Practical Clinical Enzymology Nostrand Company Limited London pp. 121-138
18. Bonting SL: Sodium-potassium activated adenosine triphosphatase and cation transport. In: E.E. Bittar (ed) Membrane and ion transport, Interscience, Vol-I, London, 1970, 257-363
19. 2+-ATPase activities in normal, regenerating and malignant cells. Biochim Biophys Acta 684: 67-74, 1982 6120003
20. 2+-ATPase from erythrocyte membranes. Biochim Biophys Acta 728: 281-288, 1983 6219703
21. Sedlak J, Lindsay RH: Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25: 192-205, 1968 10.1016/0003-2697(68)90092-4
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951 14907713
23. Goldberg MA, Antin JH, Guinan EC, Rappeport JM: Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor. Blood 68: 1114-1118, 1986 3533179
24. Shanholtz C: Acute life-threatening toxicity of cancer treatment. Crit Care Clin 17: 483-502, 2001 10.1016/S0749-0704(05)70196-2
25. Gwathmey JK, Kim CS, Hajjar RJ, Khan F, DiSalvo TG, Matsumori A, Bristow MR: Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. Am J Physiol 276: H1678-H1690, 1999 10330254
26. Koufen P, Stark G: Free radical induced inactivation of creatine kinase: Sites of interaction, protection, and recovery. Biochim Biophys Acta 1501: 44-50, 2000 10727848
27. Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P: Protective effect of DL-a-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact 151: 13-19, 2004 10.1016/j.cbi.2004.10.004
28. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R: Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 85: 68-76, 1999 10400912
29. Sylven C, Jansson E, Book K: Key enzymes of myocardial energy metabolism in patients with valvular heart disease: Relation to left ventricular function. Acta Physiol Scand 132: 267-270, 1988 2976229
30. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J: Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141: 758-763, 1981 10.1001/archinte.141.6.758
31. Schultheiss HP: Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Basic Res Cardiol 87(Suppl 1): 311-320, 1992 1497575
32. Siegel RJ, Edwalds G, Rej R, Fishbein MC: Distribution of cytosolic and mitochondrial aspartate aminotransferase in normal, ischemic, and necrotic myocardium. An immunohistochemical study. Lab Invest 51: 648-654, 1984 6389975
33. Freisleben HJ: Lipoic acid reduces ischemia-reperfusion injury in animal models. Toxicology 148: 159-171, 2000 10962135
34. Schonheit K, Gille L, Nohl H: Effect of alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion injury of the heart and heart mitochondria. Biochim Biophys Acta 1271: 335-342, 1995 7605800
35. Gardner SF, Lazarus HM, Bednarczyk EM, Creger RJ, Miraldi FD, Leisure G, Green JA: High-dose cyclophosphamide-induced myocardial damage during BMT: Assessment by positron emission tomography. Bone Marrow Transplant 12: 139-144, 1993 8401360
36. Jacob R, Lieberman M, Murphy E, Piwnica-Worms D: Effects of sodium-potassium pump inhibition and low sodium on membrane potential in cultured embryonic chick heart cells. J Physiol. 387: 549-566, 1987 2443685
37. Wutzen J: Histological and histochemical examinations of the myocardium of rats kept on low-magnesium diet and treated with cyclophosphamide. Mater Med Pol 22: 162-167, 1990 2132421
38. 2+-ATPase activity in heart and liver of streptozotocin-diabetic rats: Comparison with vitamin E. Biochim Biophys Acta 1588: 71-78, 2002 12379316
39. Levitsky DO, Levchenko TS, Saks VA, Sharov VG, Smirnov VN: The role of creatine phosphokinase in supplying energy for the calcium pump system of heart sarcoplasmic reticulum. Membr Biochem 2: 81-96, 1978 45783
40. 2+-ATPase activities and biogenic amine concentrations in phenylketonuria. Clin Biochem 35: 281-285, ]2002 10.1016/S0009-9120(02)00311-9
41. Grewal KK, Rafeiro E, Racz WJ: Bromobenzene and furosemide hepatotoxicity: Alterations in glutathione, protein thiols, and calcium. Can J Physiol Pharmacol 74: 257-264, 1996 10.1139/cjpp-74-3-257
42. Slyshenkov VS, Shevalye AA, Liopo AV, Wojtczak L: Protective role of L-methionine against free radical damage of rat brain synaptosomes. Acta Biochim Pol 49: 907-916, 2002 12545197
43. Mazur L, Blawat A: Effects of GSH and WR-2721 on induction of micronuclei by cyclophosphamide. Toxicol Lett 110: 67-72, 1999 10.1016/ S0378-4274(99)00139-3
44. Ahmed AR, Hombal SM: Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses. J Am Acad Dermatol 11: 1115-1126, 1984 6392368
45. Buja LM, Ferrans VJ, Graw RG Jr.: Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol 7: 17-45, 1976 1104469